Soleno Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Soleno Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Soleno Therapeutics Inc
Rating: 1.601847125
Author: Trendlyne DVM scores

Await Turnaround

about

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a cryst...

52.99 0.00 (0.00%)

41.33% Fall from 52W High

283.7K

XNAS Volume

XNAS 15 May, 2026 9:57 AM (EDT)

Low Financial Strength

22.2 / 100

Mid Valuation

37.3 / 100

Technically Neutral

46.4 / 100

Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM

1Yr Price target upside is 0%

8 analysts

Soleno Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Soleno Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a cryst...

41.33% Fall from 52W High

SWOT Analysis

Soleno Therapeutics Inc Live Price Chart